Rivastigmine Tartrate
These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000
bac9ca81-db70-41aa-82af-6c5bb8496846
HUMAN PRESCRIPTION DRUG LABEL
Jan 31, 2019
Sun Pharmaceutical Industries, Inc.
DUNS: 146974886
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information